Close
  • SMC open account icon Open an A/C
    • Open an A/C
    • CHOOSE YOUR OPTION(S)
    • Trading A/c
    • Mutual Fund A/c
    • NBFC A/c
    • NPS A/c
  • SENSEX Apr 26 2024 12:00
    73,730.16 -609.28 (-0.82%)
  • NIFTY Apr 26 2024 12:00
    22,419.95 -150.40 (-0.67%)
  • SENSEX Apr 26 2024 12:00
    73,730.16 -609.28 (-0.82%)
  • NIFTY Apr 26 2024 12:00
    22,419.95 -150.40 (-0.67%)
  • Nasdaq Apr 27 2024 04:30
    15,927.90 +316.14 ( +2.03%)
  • DJIA Apr 27 2024 04:30
    38,239.66 +153.86 ( +0.40%)
  • S&P 500 Apr 27 2024 04:30
    5,099.96 +51.54 ( +1.02%)
  • Hang Seng Apr 26 2024 02:10
    17,651.15 +366.61 ( +2.12%)
  • Crude Oil Apr 26 2024 11:29
    6,995.00 -4.00 (-0.06%)
  • Gold Apr 26 2024 11:29
    71,486.00 -14.00 (-0.02%)
  • Silver Apr 26 2024 11:29
    80,745.00 +65.00 ( +0.08%)
  • Copper Apr 26 2024 11:29
    859.50 +11.10 ( +1.31%)
  • Pound / Rupee Dec 23 2016 22:30
    104.10 +0.39 ( +0.38%)
  • Dollar / Rupee Dec 23 2016 22:30
    83.32 +0.01 ( +0.01%)
  • Euro / Rupee Dec 23 2016 22:30
    89.30 +0.19 ( +0.22%)
  • Yen / Rupee Dec 23 2016 22:30
    0.54 0.00 (-0.34%)

Privi Speciality Chemicals Ltd

BSE Code : 530117 | NSE Symbol : PRIVISCL | ISIN:INE959A01019| SECTOR : Chemicals |

NSE BSE
 
SMC up arrow

1,196.00

17.50 (1.48%) Volume 17458

26-Apr-2024 EOD

Prev. Close

1,178.50

Open Price

1,172.40

Bid Price (QTY)

0.00(0)

Offer Price (QTY)

0.00(0)

 

Today’s High/Low 1,205.00 - 1,168.35

52 wk High/Low 1,365.50 - 975.00

Key Stats

MARKET CAP (RS CR) 4672.29
P/E 90.48
BOOK VALUE (RS) 218.6058503
DIV (%) 0
MARKET LOT 1
EPS (TTM) 13.22
PRICE/BOOK 5.47149126319608
DIV YIELD.(%) 0
FACE VALUE (RS) 10
DELIVERABLES (%) 77.38
4

News & Announcements

25-Apr-2024

Privi Speciality Chemicals Ltd - Privi Speciality Chemicals Limited - Analysts/Institutional Investor Meet/Con. Call Updates

25-Apr-2024

Privi Speciality Chemicals Ltd - Privi Speciality Chemicals Limited - Analysts/Institutional Investor Meet/Con. Call Updates

23-Apr-2024

Privi Speciality Chemicals to discuss results

23-Apr-2024

Privi Speciality Chemicals Ltd - Privi Speciality Chemicals Limited - Board Meeting

23-Apr-2024

Privi Speciality Chemicals to discuss results

01-Nov-2023

Privi Speciality Chemicals to convene board meeting

28-Sep-2023

Privi Speciality Chemicals receives affirmation in ratings for bank facilities

26-Jul-2023

Privi Speciality Chemicals to hold board meeting

Corporate Actions

Bonus
Splits
Dividends
Rights
Capital Structure
Book Closure
Board Meeting
AGM
EGM
 

Financials

Income Statement

Standalone
Consolidated
 

Peers Comparsion

Select Company Name BSE Code NSE Symbol
Aarti Industries Ltd 524208 AARTIIND
Aarti Surfactants Ltd 543210 AARTISURF
Aarti Surfactants Ltd Partly Paidup 890180 AARTIPP
Absolute Aromatics Ltd 40209
Aditya Info-Soft Ltd 530693
Advance Petrochemicals Ltd 506947
Aether Industries Ltd 543534 AETHER
Alang Industrial Gases Ltd 531517
Alkali Metals Ltd 533029 ALKALI
Alkyl Amines Chemicals Ltd 506767 ALKYLAMINE
Allied Resins & Chemicals Ltd(merged) 524538 ALLIEDRES
Alufluoride Ltd 524634
Amal Ltd 506597
Ambani Organics Ltd 535097 AMBANIORG
Ambica Agarbathies Aroma & Industries Ltd 532335 AMBICAAGAR
Amex Carbonates & Chemicals Ltd 531321
Amines & Plasticizers Ltd 506248 AMNPLST
Aminex Chemicals Ltd (Wound-up) 524386
Amit Alcohol & Carbon Dioxide Ltd (Merged) 506904
Anan Drug & Chem Ltd 531999
Andhra Petrochemicals Ltd 500012 ANDHRAPET
Anjana Explosives Ltd 40329
Anupam Rasayan India Ltd 543275 ANURAS
Arabian Petroleum Ltd 77164 ARABIAN
Archean Chemical Industries Ltd 543657 ACI
Archit Organosys Ltd 524640
ARCL Organics Ltd 543993
Arvee Laboratories (India) Ltd 535050 ARVEE
Arvin Liquid Gases Ltd 523404
Asiatic Oxygen Ltd 40030
Atul Ltd 500027 ATUL
Avikem Resins Ltd 523784
B L Industries (India) Ltd 530637
Balaji Amines Ltd 530999 BALAMINES
Barium Chemcials Ltd 506275
Baroda Carbons Ltd 523527
BASF India Ltd 500042 BASF
Benzo Petro International Ltd 524737
Benzo Petrochemicals Ltd (Wound Up) 524196
Bhagawati Gas Ltd 500051 BAGWATIGAS
Bhagawati Oxygen Ltd 509449
Bhatia Colour Chem Ltd 543497
Bhuruka Gases Ltd 509728
Bhuvan Tripura Industries Ltd 524725
Binaca Synthetic Resins Ltd 514344
Borax Morarji Ltd(Merged) 506315
Burmah Petro Products Ltd 40310
C J Gelatine Products Ltd 507515
Cabot India Ltd 506700 CABOTINDIA
Camlin Fine Sciences Ltd 532834 CAMLINFINE
Canvay Chemicals Ltd 531535
Caprolactam Chemicals Ltd 507486
Carbon & Chemicals India Ltd (Merged) 505813
Castrol India Ltd 500870 CASTROLIND
Cellulose Products of India Ltd 506345
Chembond Chemicals Ltd 530871 CHEMBOND
Chemcon Speciality Chemicals Ltd 543233 CHEMCON
Chemcrux Enterprises Ltd 540395
Chemfab Alkalis Ltd 541269 CHEMFAB
Chemiesynth (Vapi) Ltd 539230
Chemplast Sanmar Ltd 543336 CHEMPLASTS
Chimique Laboratories (India) Ltd 40300
Ciba India Ltd(merged) 532184 CIBASPEC
Cilson Organics Ltd 532147
Citric India Ltd 506370
Citurgia Biochemicals Ltd 506373 CITURGIBIO
Clariant (India) Ltd(merged) 500373 CLARIANT
Clarisis Organics Ltd 524806
Claro India Ltd 524366
Clean Science & Technology Ltd 543318 CLEAN
Cochin Minerals & Rutile Ltd 513353
Continental Petroleums Ltd 523232
Core Organics Ltd 524466
Crestchem Ltd 526269
Dai-ichi Karkaria Ltd 526821 DAICHIKARK
DDev Plastiks Industries Ltd 543547
Deccan Petroleums Ltd 526375
Deepak Fertilizers & Petrochemicals Corp Ltd 500645 DEEPAKFERT
Deepak Nitrite Ltd 506401 DEEPAKNTR
Diamines & Chemicals Ltd 500120 DIAMINESQ
DIC India Ltd 500089 DICIND
Diviya Chemicals Ltd 506810
DMCC Speciality Chemicals Ltd 506405 DMCC
Doctors Biotech India Ltd 512079
Dujodwala Paper Chemicals Ltd 524276
Eiko Lifesciences Ltd 540204
Eiko Lifesciences Ltd Partly Paidup 890189
Elantas Beck India Ltd 500123 DRBECK
Ellenbarrie Industrial Gases Ltd 590087
Emmessar Biotech & Nutrition Ltd 524768
EPIC Enzymes Pharma & Industrial Chemicals Ltd 524374
Fairchem Organics Ltd 543252 FAIRCHEMOR
Ficom Organics Ltd(merged) 506443 FICOMORGAN
Fine Organic Industries Ltd 541557 FINEORG
Fineotex Chemical Ltd 533333 FCL
Foseco India Ltd 500150 FOSECOIND
Futuristic Offshore Services and Chemical Ltd 500154 GANESHANHY
Gagan Gases Ltd 524624
Galaxy Oleo-Chem (India) Ltd 40207
Galaxy Surfactants Ltd 540935 GALAXYSURF
GBL Industries Ltd 539009
GHCL Ltd 500171 GHCL
Glory Chemicals Ltd 531532
GOCL Corporation Ltd 506480 GOCLCORP
Godrej Industries Ltd 500164 GODREJIND
Goiex Michio Sudo Ltd 507978
GOM Industries Ltd 523802
Goodearth Industries Ltd 526929
Goodearth Organic (India) Ltd [Wound-up] 524300
Govind Poy Oxygen Ltd 509586
GP Petroleums Ltd 532543 GULFPETRO
Grauer & Weil (India) Ltd 505710 GRAUWEIL
Gresoil (India) Ltd 530483
Gujarat Carbon & Industries Ltd 506457
Gujarat Fluorochemicals Ltd 542812 FLUOROCHEM
Gujarat Indo-Lube Ltd 523552
Gujarat Narmada Valley Fertilizers & Chemicals Ltd 500670 GNFC
Gujarat Oiland Industries Ltd (Wound Up) 507866
Gujarat Organics Ltd 501368
Gujarat Speciality Lubes Ltd 523880
Gulf Oil India Ltd - Merged 511026 GULFOIL
Gulf Oil Lubricants India Ltd 538567 GULFOILLUB
Gulshan Sugars & Chemicals Ltd(merged) 524184
Haryana Leather Chemicals Ltd 524080
Hemo Organic Ltd 524590
Hico Products Ltd 506461
Hi-Green Carbon Ltd 91663 HIGREEN
Hilltone Industrial Gases Ltd 40441
Himadri Speciality Chemical Ltd 500184 HSCL
Hindcon Chemicals Ltd 535053 HINDCON
Hindustan Industrial Chemicals Ltd 524679 HINDINDCHM
Hindustan Organic Chemicals Ltd 500449 HOCL
Hindustan Oxygen Gas Ltd 509660
HP Adhesives Ltd 543433 HPAL
Hubergroup India Pvt Ltd 523886 MICRO
I G Petrochemicals Ltd 500199 IGPL
IBP Co. Ltd(merged) 500198 IBP
Iccon Oil & Specialities Ltd 523766
India Carbon Ltd 40012
India Gelatine & Chemicals Ltd 531253
Indian Electro Chemicals Ltd 506490
Indo Amines Ltd 524648 INDOAMIN
Indo Borax & Chemicals Ltd 524342 INDOBORAX
Indo Gulf Industries Ltd 506945
Indo Vanillon Chemicals Ltd 531267
Indu Nissan Oxo Chemicals Industries Ltd 500208 INDUNISSAN
Inox Air Products Pvt Ltd 526534 INDOXYGEN
Insilco Ltd 500211 INSILCO
Iota Chemiculture Ltd(Liquidated) 524630
IVP Ltd 507580 IVP
J F Laboratories Ltd 523804 JFLABS
J.G.Chemicals Ltd 544138 JGCHEM
J.R. Organics Ltd 506650
Jay Agrochem Ltd (Wound Up) 513504
Jayant Agro Organics Ltd 524330 JAYAGROGN
Jocil Ltd 500561 JOCIL
Jubilant Industries Ltd 533320 JUBLINDS
Jubilant Ingrevia Ltd 543271 JUBLINGREA
Jyoti Resins and Adhesives Ltd 514448
K P Gelatines & Chemicals India Ltd (Wound-up) 524741
Kamar Chemicals & Industries Ltd 531001
Kanchi Karpooram Ltd 538896
Kanoria Chemicals & Industries Ltd 506525 KANORICHEM
Kanva Hydro Chem Ltd 524685
Karnataka Chemical Industries Corp Ltd 530105
Karnav Leather Chemicals Ltd 524432
Keltech Energies Ltd 506528
Kesar Petroproducts Ltd 524174
Kilburn Chemicals Ltd 524699
Kings India Chemicals Corporation Ltd 524214
Kothari Polymers Ltd 40360
Krishna Plastochem Ltd (Wound Up) 524254
Laxmi Organic Industries Ltd 543277 LXCHEM
Lime Chemicals Ltd 507759
Linde India Ltd 523457 LINDEINDIA
Link Pharma Chem Ltd 524748
Lords Chemicals Ltd 530039
M.P. Carbide & Chemicals Ltd 506925
Madras Petrochem Ltd 500261
Maha Chemicals Ltd (Wound-up) 524556
Maharashtra Explosives Ltd (Wound-up) 506871
Maharashtra Polybutenes Ltd 524232
Mangalam Organics Ltd 514418 MANORG
Mark Omega Organic Industries Ltd 524681
Maruti Industrial Carbohydrates Ltd 524814
Maruti Organics Ltd 524402 MARUTIORNG
Master Chemicals Ltd 506867
Mehta Rubber Chemcials Ltd 526536
Mehta Sulfites (India) Ltd 530029
mk Aromatics Ltd 531011
Motorol (I) Ltd 508965 MOTOROL
Motorol Enterprises Ltd 523049 RINKIPETRO
Motorol Speciality Oils Ltd 506954
MTZ Industries Ltd 500275 METAZINC
Murablack India Ltd 523578 MURABLACK
Nacro Chemicals Ltd 524350
Nariman Point Chemical Industries Ltd 524224
Narmada Gelatines Ltd 526739 SHAWGELTIN
National Oxygen Ltd 507813 NOL
Navin Fluorine International Ltd 532504 NAVINFLUOR
Neogen Chemicals Ltd 542665 NEOGEN
Newton Engineering & Chemicals Ltd 524474
Nikhil Adhesives Ltd 526159
Niraj Petrochemicals Ltd 500454 NIRAJPETRO
Nitta Gelatin India Ltd 506532 KERALACHEM
NLC Nalco India Ltd 524101 NALCOCHEM
Noble Explochem Ltd 506991
NOCIL Ltd 500730 NOCIL
Nouryon Chemical India Pvt Ltd 500082 CENTAKCHEM
Nova Chemie (India) Ltd 40188
Ojas Technochem Products Ltd(wound-up) 526427
Omkar Speciality Chemicals Ltd 533317 OMKARCHEM
Organic Coatings Ltd 531157
Orient Organics Ltd 524766
Oriental Aromatics Ltd 500078 OAL
Oriental Carbon & Chemicals Ltd 506579 OCCL
Orissaa Organics Ltd 524392
Oswali Chemicals Ltd 506916
Padmanabh Industries Ltd 526905
Paintex Chemicals (Bombay) Ltd 524178
Paragon Fine and Speciality Chemical Ltd 91901 PARAGON
Paschim Petrochem Ltd 531005
Paushak Ltd 532742
PCBL Ltd 506590 PCBL
Pentasia Chemicals Ltd (Merged) 507739
Pidilite Industries Ltd 500331 PIDILITIND
Pinky Chemicals Ltd 524671
Plastiblends India Ltd 523648 PLASTIBLEN
Platinum Industries Ltd 544134 PLATIND
Polyolefins Industries Ltd (Merged) 506610
Premier Explosives Ltd 526247 PREMEXPLN
Protchem Industries (India) Ltd 524117
Rain Calcining Ltd(merged) 532153 RAINCALCIN
Rathi India Ltd 506959
Refnol Resins & Chemicals Ltd(Merged) 530815
Rencal Chemicals (India) Ltd 524510
Resonance Specialities Ltd 524218
Revati Organics Ltd 524504
Rhodia Specialty Chemicals India Ltd(Merged) 506230 ALBRMORARJ
Rite Zone Chemcon India Ltd 535489 RITEZONE
Ritesh International Ltd 519097
Rock Hard Petro Chemical Industries Ltd 524194
Rossari Biotech Ltd 543213 ROSSARI
Rukmani Metals & Gaseous Ltd 40695
S H Kelkar & Company Ltd 539450 SHK
S K R Chemicals Ltd 530371
Sadhana Nitro Chem Ltd 506642 SADHNANIQ
Salvigor Laboratories Ltd (Merged) 524268
Sanderson Industries Ltd 507728 SANDERIND
Sanginita Chemicals Ltd 538408 SANGINITA
Sarang Chemicals Ltd 532031
Searsole Chemicals Ltd (Wound-up) 506644
Seya Industries Ltd 524324 SEYAIND
Shaper Chemicals Ltd (Wound-up) 524566
Shayona Petrochem Ltd 531538
Shentracon Chemicals Ltd 530757
Shree Benzophen Industries Ltd 531389
Shree Neelachal Laboratories Ltd 531487
Shri Ambuja Petro Chemicals Ltd 506742
Shri Aster Silicates Ltd 533219 SHRIASTER
Shri Nicosect Ltd 526437
SI Group - India Ltd 506460 SIGROUPIND
SMZS Chemicals Ltd(wound-up) 524160 SMZSCHEM
Solar Industries India Ltd 532725 SOLARINDS
Sonal Sil Chem Ltd 524673
Southern Gas Ltd 509910
Speciality Petrolubes Ltd 523525
Sree Rayalaseema Hi-Strength Hypo Ltd 532842 SRHHYPOLTD
Sree Rayalaseema Petrochemicals Ltd (Merged) 524618
Sreechem Resins Ltd 514248
SRF Ltd 503806 SRF
SRHHL Industries Ltd (Merged) 524410 SRHHLINDST
Sterling Biotech Ltd 512299 STERLINBIO
Sudev Chemicals Ltd 40666
Sun Star Chemicals Ltd 524536 SUNSTRCHEM
Sunshield Chemicals Ltd 530845
Sunstar Lubricants Ltd 524452 SUNSTARLUB
Superior Air Products Ltd (Merged) 526469
Swarnajyothi Agrotech & Power Ltd 590090
Tamil Nadu Industrial Explosives Ltd 524028
Tamil Nadu Petro Products Ltd 500777 TNPETRO
Tanfac Industries Ltd 506854 TANFACIND
Tata Chemicals Ltd 500770 TATACHEM
Tatva Chintan Pharma Chem Ltd 543321 TATVA
TECIL Chemical & Hydro Power Ltd 506680 TECILCHEM
Tetrahedron Ltd 40308
Thirani Chemicals Ltd (Merged) 524125
Thirumalai Chemicals Ltd 500412 TIRUMALCHM
Tide Water Oil Co (I) Ltd 590005 TIDEWATER
Tirupati Inks Ltd 533258
Transpek Industry Ltd 506687 TRANSPEK
Tria Fine Chem Ltd 524721
Tribology India Ltd 40171
Trigon Zinco Ltd 530287
Tulasee Bio-Ethanol Ltd 524514
U P Lime Chem Ltd 524677
Unique Oils India Ltd 523250
Urvi Chemicals & Allied Industries Ltd 501371
Vadilal Chemicals Ltd 40485
Vadivarhe Speciality Chemicals Ltd 538429 VSCL
Valiant Organics Ltd 540145 VALIANTORG
VBC Industries Ltd 524310
Vibros Organics Ltd 530487
Vijayshree Chemicals (India) Ltd 524312
Vikas Wsp Ltd 519307 VIKASWSP
Vinati Organics Ltd 524200 VINATIORGA
Vishnu Chemicals Ltd 516072 VISHNU
Vision Organics Ltd 532383 VISIONLTD
Vital Chemtech Ltd 535490 VITAL
Yasho Industries Ltd 541167 YASHO
Yug Decor Ltd 540550

Share Holding

Category No. of shares Percentage
Total Foreign 2955569 7.57
Total Institutions 1317892 3.37
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 439671 1.13
Total Promoters 28925601 74.05
Total Public & others 5423973 13.88
Total 39062706 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

About Privi Speciality Chemicals Ltd

Privi Speciality Chemicals Limited (formerly known as Fairchem Speciality Limited) is India's leading manufacturer, supplier, and exporter of aroma and fragrance chemicals and a globally trusted partner and supplier of bulk aroma chemicals. The Company has in-house integrated manufacturing facilities situated at Mahad in Maharashtra and Jhagadia in Gujarat with knowledge, expertise and capacity to perform critical reactions like Hydrogenation, Condensation, Grignard reactions, as well as unit operations like Pyrolysis, Reactive Distillation, High Vacuum Distillation, Continuous Distillation to deliver consistency. The Company incorporated in May 25th, 1985. It started manufacturing aroma chemicals in year 1992 with only two products, which it gradually expanded to a range of over 50 products as of today, having a capacity of over 32,500 tons per annum. It develops and produces custom-made aroma chemicals as per specific requirement of the customers. The company came out with a public issue in Feb.'95 to set up facilities at Sanand, near Ahmedabad, to manufacture 3248 tpa of distilled fatty acids like oleic acid, linoleic acid and palmitic acid; 2894 tpa of rice bran oil grade-1 and 625 tpa of monoglycerides. Company has made private placement in 1996-97, having paid up equity from 7.00 Crores to 8.50 Crores The company has a technical collaboration with UIC, US. Equipment were procured from Sulzer, Switzerland; Feld & Hahn, Germany and UIC, US. During the year 1996-97, the second phase of Short Path Distillation Plant commenced its commercial production in the month of Nov'96. Company has export his main product viz.Deodorizer Distillate (Mixed Tocopherols) to Henkel Corporation who has buy entire production of this product. Company has placed the orders for putting up continuous fat splitting plant, which helps the company to upgrading the second stream of by product viz-Residual Oil by converting into split Fatty Acid, which can be upgraded by further processing in Fractionation plant & increased value of domestic sales. During 1999-2000, the company has successfully commissioned Fat Splitting Plant' to increase the availiability of high value fatty acids for sale in domestic market. In 2001, Company started making Dimer Acid and Monobasic Acid by using one of its finished product streams. During year 2004, Company enhanced its annual raw material throughput capacity to 6,000 MT. In year 2006, it carried out laboratory trials of further concentration of Tocopherols. During the year 2010, name of the Company changed from H.K. Finechem Limited to Adi Finechem Limited w.e.f. 19th October, 2010. In 2011, it focused more on reduction of manufacturing cost per ton. It went through a complete re-engineering of its Energy Consumption System and Installation of new balancing equipments. The raw material throughput capacity was increased from 8,000 M.Tons to 12,000 M.Tons during the year. In 2013, the Company increased manufacturing capacity further to 18,000 MTPA. In 2014, Company increased its installed capacity to 24,000 MTPA and undertook CAPEX to increase this capacity to 45,000 MT p.a. In 2015, it further increased installed capacity to 45,000 MTPA. The Canada- based Fairfax Group signed a Share Purchase Agreement with existing (Indian) Promoters and acquired 45% equity stake in the Company, which completed in February, 2016. During Q3 of year 2015, Company commissioned new High Pressure Fat Splitting Plant and a new Fractionation column was commissioned. During the year 2016, Company commissioned its new Dimerization plant. In August, 2016, Fairfax acquired 51% equity stake in Privi Organics Limited whose business of Aroma Chemicals is now vested in the Company's wholly owned subsidiary company as per Scheme of Arrangement. Pursuant to Order of NCLT dated 30 June 2020, a Composite Scheme of Arrangement and Amalgamation was approved amongst Fairchem Speciality Limited (Demerged/Transferee Company), Fairchem Organics Limited (Resulting Company) and Privi Organics India Limited (Transferor Company) and their respective Shareholders, through which business of Privi Organics India Limited (POIL) merged into Fairchem Speciality Limited (FSL). Therefore, the business activities of the Company (FSL) has been demerged/transferred to FOL. In 2022, Company signed a Joint Venture Agreement with Givaudan SA, a Company incorporated in Switzerland, for manufacturing highly specialized aroma Chemicals for Givaudan and a new Subsidiary, Prigiv Specialties Private Limited incorporated on September 01, 2021, wherein Company controls 51% of total voting power.

Privi Speciality Chemicals Ltd Chairman Speech

IN THE PAST THREE YEARS, WE HAVE COMPLETED PROJECTS TO MANUFACTURE GALAXMUSK, CAMPHOR AND PRIONYL WITH CAPACITIES TO CAPTURE GLOBAL MARKET SHARE AND SUPPORTED BY STATE-OF-THE-ART MANUFACTURING PLANTS.

DEAR SHAREHOLDERS

Warm greetings from Privi family!

With pleasure and renewed optimism, I take this opportunity to address you.

Undoubtedly, the past three years have been challenging on every dimension. COVID-19 and the lockdowns delayed implementation of projects by almost one year. Central banks led by the US Fed have increased interest rates many folds to a level last seen - only briefly - during the financial crisis of 2008.

Significant rise in the interest rate, energy crisis as a result of Ukraine-Russia war, has slowed down the economic activities considerably. Indeed, in its latest report published in April 2023, the IMF has forecast global growth rate of 2.8% p.a. with the developed world growing at a meagre 1.3%. This is the lowest forecast in decades. Countries like Germany, the United Kingdom are witnessing negative growth. Of course, India is expected to grow at 5.9%, however, as about 70% of our revenues are from exports to the developed world, we are impacted by the developments in the developed markets.

Amidst this situation, I firmly believe that in the medium to long run, companies which are cost competitive, practice holistic sustainable policies will retain the market share in key products and will increase customer share supported by introduction of new products.

I am, therefore, personally very sanguine about the future prospects for your Company in specific and for India in general, as your Company has been embarking upon various Capex for both new products and also on increasing capacities of existing products. Your Company has also been focussing on ensuring that sustainable and environment-friendly practices are followed in manufacturing process across all units at both Mahad and Jhagadia operations.

In the past three years, we have completed projects to manufacture Galaxmusk, Camphor and Prionyl with capacities to capture global market share and supported by state-of-the- art manufacturing plants. Delays in implementation of these projects, as a result of lockdowns during COVID-19 and in obtaining necessary regulatory permissions has severely impacted our financial performance for FY 2022-23. As timing of product launch plays a crucial role in annual business contracts, even a couple of months' delay in launching a product can significantly impact the following year business contracts. Your Company's performance was severely impacted by such delays.

Thus, while the new projects have started to generate some revenues and profits from the 4th quarter of Financial Year 2022-23, depreciation charges and the interest cost has been accounted for almost nine months of the year. Your Company has been able to achieve a growth in revenues by Rs.186.38 crores registering a growth of 13.39%. However, because of high coal costs, depreciation and interest costs, the net profit for the year has been severely affected. The net profit after tax has reduced from Rs.101.66 crores to Rs.22.47 crores.

It is pertinent to note that the financial year 2023-24 has begun on a positive note. New products have been approved by all the key customers and there is a very good traction on sales for these products.

Sustainability is one of the Core Values of your Company. Your Company is taking various majors driven by Science Based Targets (SBT) to reduce emissions, incorporate green power, etc. I am happy to announce that at Unit-10, which houses Mahad corporate offices and supply chain centre, is now powered by solar panels installed on the rooftop. Apart from saving in the electricity charges, it also helps your Company to meet the sustainability targets. Your Company has also acquired 26% equity in a Special Purpose Vehicle (SPV) formed to invest in a solar power plant, which will meet about 25% of the power requirement of Unit-2 - the largest manufacturing plant of your Company. Your Company has also been working on significantly reducing the discharge of water and increasing the reuse of water generated from the effluents, by investing in a state-of-the-art effluent treatment plant. These measures will considerably strengthen the sustainability of your Company.

Before I close, let me once again assure you that the difficult times are behind us, and the times to come, starting from this financial year, your Company will start to reap benefits from the investments made in the past few years.

I want to thank all members of the Board of Directors, my colleagues, my business partners, our bankers and most of all the members of my shareholder family for the support and faith reposed in us.

With warm regards,

Mahesh P. Babani

Chairman and Managing Director.

   

Privi Speciality Chemicals Ltd Company History

Privi Speciality Chemicals Limited (formerly known as Fairchem Speciality Limited) is India's leading manufacturer, supplier, and exporter of aroma and fragrance chemicals and a globally trusted partner and supplier of bulk aroma chemicals. The Company has in-house integrated manufacturing facilities situated at Mahad in Maharashtra and Jhagadia in Gujarat with knowledge, expertise and capacity to perform critical reactions like Hydrogenation, Condensation, Grignard reactions, as well as unit operations like Pyrolysis, Reactive Distillation, High Vacuum Distillation, Continuous Distillation to deliver consistency. The Company incorporated in May 25th, 1985. It started manufacturing aroma chemicals in year 1992 with only two products, which it gradually expanded to a range of over 50 products as of today, having a capacity of over 32,500 tons per annum. It develops and produces custom-made aroma chemicals as per specific requirement of the customers. The company came out with a public issue in Feb.'95 to set up facilities at Sanand, near Ahmedabad, to manufacture 3248 tpa of distilled fatty acids like oleic acid, linoleic acid and palmitic acid; 2894 tpa of rice bran oil grade-1 and 625 tpa of monoglycerides. Company has made private placement in 1996-97, having paid up equity from 7.00 Crores to 8.50 Crores The company has a technical collaboration with UIC, US. Equipment were procured from Sulzer, Switzerland; Feld & Hahn, Germany and UIC, US. During the year 1996-97, the second phase of Short Path Distillation Plant commenced its commercial production in the month of Nov'96. Company has export his main product viz.Deodorizer Distillate (Mixed Tocopherols) to Henkel Corporation who has buy entire production of this product. Company has placed the orders for putting up continuous fat splitting plant, which helps the company to upgrading the second stream of by product viz-Residual Oil by converting into split Fatty Acid, which can be upgraded by further processing in Fractionation plant & increased value of domestic sales. During 1999-2000, the company has successfully commissioned Fat Splitting Plant' to increase the availiability of high value fatty acids for sale in domestic market. In 2001, Company started making Dimer Acid and Monobasic Acid by using one of its finished product streams. During year 2004, Company enhanced its annual raw material throughput capacity to 6,000 MT. In year 2006, it carried out laboratory trials of further concentration of Tocopherols. During the year 2010, name of the Company changed from H.K. Finechem Limited to Adi Finechem Limited w.e.f. 19th October, 2010. In 2011, it focused more on reduction of manufacturing cost per ton. It went through a complete re-engineering of its Energy Consumption System and Installation of new balancing equipments. The raw material throughput capacity was increased from 8,000 M.Tons to 12,000 M.Tons during the year. In 2013, the Company increased manufacturing capacity further to 18,000 MTPA. In 2014, Company increased its installed capacity to 24,000 MTPA and undertook CAPEX to increase this capacity to 45,000 MT p.a. In 2015, it further increased installed capacity to 45,000 MTPA. The Canada- based Fairfax Group signed a Share Purchase Agreement with existing (Indian) Promoters and acquired 45% equity stake in the Company, which completed in February, 2016. During Q3 of year 2015, Company commissioned new High Pressure Fat Splitting Plant and a new Fractionation column was commissioned. During the year 2016, Company commissioned its new Dimerization plant. In August, 2016, Fairfax acquired 51% equity stake in Privi Organics Limited whose business of Aroma Chemicals is now vested in the Company's wholly owned subsidiary company as per Scheme of Arrangement. Pursuant to Order of NCLT dated 30 June 2020, a Composite Scheme of Arrangement and Amalgamation was approved amongst Fairchem Speciality Limited (Demerged/Transferee Company), Fairchem Organics Limited (Resulting Company) and Privi Organics India Limited (Transferor Company) and their respective Shareholders, through which business of Privi Organics India Limited (POIL) merged into Fairchem Speciality Limited (FSL). Therefore, the business activities of the Company (FSL) has been demerged/transferred to FOL. In 2022, Company signed a Joint Venture Agreement with Givaudan SA, a Company incorporated in Switzerland, for manufacturing highly specialized aroma Chemicals for Givaudan and a new Subsidiary, Prigiv Specialties Private Limited incorporated on September 01, 2021, wherein Company controls 51% of total voting power.

Privi Speciality Chemicals Ltd Directors Reports

Your Directors' are pleased to present the Thirty Eighth Annual Report along with audited financial statements - both Standalone and Consolidated of the Company for the financial year ended March 31, 2023. These financial statements have been prepared in accordance with Indian Accounting Standards (Ind-AS) as required under the Companies Act, 2013 ("the Act"). This report states compliance as per the requirements of the Act, the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") and other rules and regulations as applicable to the Company.

FINANCIAL RESULT

(Rs. In Lakhs)
Particulars

Standalone for the year ended on 31-03-2022

Consolidated for the year ended on 31-03-2022

Total Income 1,59.943.93 1,42,406.49 1,62,924.15 1,43,611.48
Profit before Exceptional Item Interest & Depreciation & Taxation 20,305.13 22,818.50 20,734.31 22,623.55
Less: Interest 6,662.48 2,377.64 6,781.31 2,411.28
Profit before Exceptional Item, Depreciation and Taxation 13,642.65 20,440.86 13,953.00 20,212.27
Less: Depreciation 10,515.53 7,304.39 10,848.67 7,466.15
Profit before Exceptional Item and Taxation 3,127.12 13,136.47 3,104.33 12,746.12
Add: Exceptional Item - 529.24 - 529.24
Profit before Tax for the year 3,127.12 13,665.71 3,104.33 13,275.36
Less: Provision for Taxation:
a) Current Tax 333.81 3,395.97 334.73 3,521.57
b) Deferred Tax 545.82 103.26 641.79 15.81
c) Tax adjustments for earlier years (Net) - - - -
Sub-Total 879.63 3,499.23 976.52 3,537.38
Profit after Tax for the year 2,247.49 10,166.48 2,127.81 9,737.98
Add: Other Comprehensive Income 45.61 (43.65) 240.55 17.52
Total Comprehensive Income for the year 2,293.10 10,122.83 2,368.36 9,755.50
Earnings Per Share (EPS) of Rs.10/- each 5.75 26.03 5.45 24.93

OPERATIONS AND THE STATE OF COMPANY'S AFFAIRS (CONSOLIDATED):

During the year under review, the consolidated revenue from operations and other income was Rs.1,62,924.95 Lakhs (Previous year Rs.1,43,611.48 Lakhs). The Company achieved consolidated profit before tax of Rs.3,104.33 Lakhs (Previous year Rs.13,275.36 Lakhs) and profit after tax & Other Compressive Income of Rs.2,368.36 Lakhs (Previous year Rs.9,755.50 Lakhs). The EPS on Consolidated financial statements for the year ended March 31, 2023, was Rs.5.45 (Previous year Rs.24.93) on diluted basis.

CAPITAL STRUCTURE:

During the year, there was no change in the Capital structure i.e., Authorized, Issued and Paid-up Equity Share Capital of the Company. The Company is having only one class of shares.

DIVIDEND:

The Board of Directors of your company, after considering holistically the relevant circumstances and keeping in view the company's dividend distribution policy, has decided that it would be prudent not to recommend any Dividend for the year under review.

SUBSIDIARY COMPANIES:

Your Company has three Subsidiaries out of which two are wholly owned subsidiaries namely Privi Biotechnologies Private Limited and Privi Speciality USA Corporation (formerly known as Privi Organics USA Corporation).

Your Company entered into a Joint Venture Agreement with Givaudan SA, a Company incorporated in Switzerland, for manufacturing highly specialized aroma Chemicals for Givaudan and a new Subsidiary Company Prigiv Specialties Private Limited was incorporated on September 01, 2021, wherein your Company controls 51% of total voting power and also controls the Composition of Board of Directors.

The Consolidated Financial Statements presented by the Company includes the financial results of its subsidiary companies. Further, as provided in Section 136 of the Act, the Balance Sheet, Statement of Profit and Loss and other documents of the subsidiary companies are not attached to the Financial Statements of the Company. The Company will make available free of cost the Audited Financial Statements of the subsidiary companies and the related detailed information to any member of the Company who may be interested in obtaining the same. The Financial Statements of the subsidiary companies will also be kept open for inspection at the Registered Office of the Company and that of the respective subsidiary companies.

As provided in Section 129[3] of the Act and Rules made thereunder a statement containing the salient features of the financial statements of its subsidiaries in the format AOC 1 is attached to the financial statements as Annexure - 1.

TRANSFER TO RESERVES:

The Board of Directors have decided to retain the entire number of Profits for Financial year 2022-23 in the Retained Earnings.

MAJOR EVENTS OCCURRED DURING THE YEAR UNDER REVIEW:

a) Reclassification of Promoter to Public (in April 2022)

Your Directors' wish to inform the Members about the material event being inter-se transfer of shares between the Promoter/ Promoter Group, which took place on April 29, 2021, April 30, 2021 and May 04, 2021. The said interse transfer is pursuant to Share Purchase Agreement dated May 22, 2019 (Amended on April 22, 2021) and Company had submitted application to BSE Limited ("BSE") & National Stock Exchange of India Limited ("NSE") for reclassification of below mentioned Promoters/ Promoter Group to Public:

1. Mr. Nahoosh Jayvadhan Jariwala

2. Nahoosh Tradelink LLP

3. Jariwala Tradelink LLP

4. Mr. Utkarsh Shah

5. FIH Mauritius Investments Limited

6. FIH Private Investments Limited

The Company has received the letter of approval for reclassification of the above Promoters/Promoters group to Public from BSE & NSE on April 28, 2022.

b) Commencement of Commercial Production of two new project Galax musk & Camphor

In the month of January 2023, your Company has commenced with the commercial production of Company's two ambitious and prestigious new products, Galax-musk at Unit VI, situated at Jhagadia MIDC, Dist., Bharuch, Gujarat and Camphor at Unit II, situated at Mahad MIDC, District Raigad, Maharashtra.

c) Investment in Solar Power Project

The Board of Directors of your Company had approved an investment in the Solar Power Project, by way of Equity participation through a Special Purpose Vehicle (SPV) to the extent of 26% i.e. Rs.4,99,50,000 (Four Crores Ninety Nine Lakhs Fifty Thousand Only) comprising of 49,95,000 Equity Shares of Rs.10/- each of the Share Capital of the SPV subject to finalization of the terms and conditions with the proposed SPV. Your Company has entered into a Power Purchase agreement (PPA) dated December 28, 2022, and a Share Subscription and Shareholders Agreement (SSSHA) dated December 28, 2022. Further your Company have also subscribed to the 1st tranche of said investment amounting to Rs.10,00,000 (' Ten Lakhs Only) out of the agreed subscription of Rs.4,99,50,000 (Four Crores Ninety Nine Lakhs Fifty Thousand Only) by way of renunciation under the rights issue of SPV.

BUSINESS RESPONSIBILITY AND SUSTAINABILITY REPORT:

Your Company has a culture and belief of sustainable development encompassing sustainable manufacturing, product safety, economy analysis, sustainability-oriented supply chain management and social and community based sustainable requirement. Pursuant to Regulation 34(2)(f) of Listing Regulations, 2015 and in line with the SEBI Circulars dated May 05, 2021 and May 10, 2021, inter alia, provides that the Annual Report of the Top 1000 listed entities based on Market Capitalization, should include a Business Responsibility and Sustainability Report ("BRSR").

The BRSR initiatives taken from an Environmental, Social and Governance perspective in the prescribed format is available as a Separate Section of this Report.

DEPOSITS FROM PUBLIC:

The Company has not accepted any Deposits from public and as such no amount on account of Principle or interest on Deposit from public was outstanding as on the date of the Balance Sheet.

DIVIDEND DISTRIBUTION POLICY

In accordance with Regulation 43A of the SEBI Listing Regulations, the Board of Directors of the Company has adopted a Dividend Distribution Policy ('Policy') which endeavor for fairness, consistency and sustainability while distributing profits to the shareholders. The Policy is available on the Company's website at http://www.privi.com/investor-relations/corporate-aovernance/ company-policies

CREDIT RATING:

The Company's credit rating was reaffirmed during the year under review. CRISIL Ratings Limited vide its letter dated September 01, 2022, have reaffirmed the rating as follows:

1. For Long-term Bank facilities: CRISIL A+ / Stable (Reaffirmed)

2. For Short term Bank facilities: CRISIL A1 / (Reaffirmed)

INVESTOR EDUCATION AND PROTECTION FUND (IEPF):

In accordance with the applicable provisions of the Act, read with Investor Education and Protection Fund (Accounting, Audit, Transfer and Refund) Rules, 2016 ("IEPF Rules"), all unclaimed dividends are required to be transferred by the Company to the IEPF, after completion of seven (7) years. Further, according to IEPF Rules, the shares on which dividend has not been claimed by the shareholders for seven (7) consecutive years or more shall be transferred to the demat account of the IEPF Authority. The details relating to the amount of dividend transferred to the IEPF and corresponding shares on which dividends were unclaimed for seven (7) consecutive years, are provided in the General Shareholders Information Section of this Annual Report. During the year, an amount of Rs.3,40,550/-, being unclaimed dividend for F.Y. 2014-15 was transferred to IEPF.

DETAILS OF NODAL OFFICER:

According to rule 7(2A), each company shall nominate a Nodal Officer, who shall either be a Director or Chief Financial Officer or Company Secretary of the company. During the year under review the Company have appointed Ms. Ashwini Saumil Shah, Company Secretary and Compliance Officer of the Company as a Nodal Officer as per the abovesaid rule.

TECHNICAL ACHIEVEMENT:

The Company keeps on exploring the possibility of technical improvement and process optimization for better yields / product mix / energy efficiency.

COMPANY'S POLICY ON DIRECTORS' APPOINTMENT AND REMUNERATION INCLUDING CRITERIA FOR DETERMINING QUALIFICATIONS, POSITIVE ATTRIBUTES, INDEPENDENCE OF A DIRECTOR ETC.:

Pursuant to the provisions of Section 178 and other applicable provisions, if any, of the Act, read with the Rules made thereunder and Regulation 19 read with Part D of Schedule II of the Listing Regulations the Board of Directors at their Meeting held on November 05, 2020, approved the Nomination and Remuneration

Policy as recommended by the Nomination and Remuneration Committee. The salient features of the said policy covering the policy on appointment and remuneration and other matters have been provided in the Corporate Governance Report.

BOARD EVALUATION:

The Evaluation of Board, its Committees, Individual Directors (Independent and Non-Independent Directors), Executive Director and Chairman & Managing Director was carried out as per the process and criteria laid down by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee. The evaluation report criteria for Independent Directors includes participation and contribution by a director in Board / Committee Meetings, commitment, expertise, integrity, maintenance of confidentiality and independent behavior. The feedback on evaluation of the Board and its Committees was discussed at the meeting of the Independent Directors and coordinated by the Chairperson of the Nomination & Remuneration Committee. The Independent Directors met on March 24, 2023, with respect to the above process.

DIRECTORS' RESPONSIBILITY STATEMENT:

Pursuant to the requirement of Section 134(3)(c) of the Companies Act, 2013 and to the best of their knowledge and belief, and according to the information and explanations provided to them, your Directors hereby make the following statements:

(i) that in the preparation of the financial statements for the year ended March 31,2023, the applicable accounting standards read with requirements set out under Schedule III of the Companies Act, 2013 have been followed and there are no material departures from the same;

(ii) that the Directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year viz. March 31,2023, and of the profit of the Company for that period;

(iii) that the Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities.

(iv) that the Directors have prepared the annual accounts on a 'Going Concern' basis.

(v) that the Directors have laid down internal financial controls to be followed by the company and that such internal financial controls are adequate and were operating effectively and

(vi) that the Directors have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems are adequate and operating effectively.

DIRECTORS:

During the year under review there is no change in the composition of the Board of Directors.

Re-appointment

In Accordance with the provisions of Section 152 of the Act and Articles of Association of the Company, Mr. Bhaktavatsala Doppalapudi Rao (DIN 00356218), Executive Director of the Company, retires by rotation at the ensuing Annual General Meeting and being eligible for re-appointment.

Mr. Dwarko Topandas Khilnani (DIN: 01824655) and Mr. Anurag Surana (DIN: 00006665) shall be completing their first term of five years as an Independent Director of the Company on March 31, 2024. Nomination and Remuneration Committee and Board of Directors in their Meeting held on May 29, 2023, have recommended to Shareholders of the Company, the re-appointment of Mr. Khilnani & Mr. Surana for the second consecutive term of five years commencing from April 01, 2024, to March 31, 2029.

KEY MANAGEMENT PERSONNEL (KMP):

During the year under review Mr. Ramesh Kathuria (ACS: 11214) resigned from the post of Company Secretary and Compliance officer w.e.f. closing hours of November 07, 2022. He will continue to serve the Company as Group Company Secretary and Head Legal. Ms. Ashwini Saumil Shah (ACS: 58378) was appointed as Company Secretary & Compliance Officer w.e.f. opening hours of November 08, 2022.

In terms of Provisions of Section 251 and Section 203 of the Act, the followings are the KMP's of the Company:

1. Mr. Narayan S. Iyer - Chief Financial Officer

2. Ms. Ashwini Saumil Shah - Company Secretary & Compliance Officer

STATEMENT ON DECLARATION GIVEN BY INDEPENDENT DIRECTORS:

The Company has received declarations from all the Independent Directors of the Company, inter alia, confirming that they meet the criteria of Independence as prescribed under Section 149 of the Act and Regulation 16(1)(b) of Listing Regulations, as amended from Independent Directors confirming that they are not disqualified for continuing as an Independent Director.

PARTICULARS OF EMPLOYEES:

Disclosures pertaining to remuneration and other details as required under Section 197(12) of the Act read with Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 are annexed to this report.

The Statement containing particulars of employees as required under Section 197 (12) of the Act read with Rule 5(20 and 5(3) of the Rules forms part of this Report. Further, the Report and the Accounts are being sent to the Members excluding the aforesaid Statement. The said statement is open for inspection upon request by the Members. Any Member interested in obtaining such particulars may write to the Company Secretary at investors@privi.co.in.

LISTING:

The Company's securities are listed with BSE Limited and National Stock Exchange of India Limited. The Company has paid the listing fees for F.Y. 2023-24 on the Paid-up equity share capital.

RELATED PARTY TRANSACTIONS:

The Company has formulated a Policy on Related Party Transactions, in line with the requirements of the Act, and Listing Regulations, as amended from time to time. The policy on Related Party Transactions as approved by the Board is uploaded on the Company's website at https://www.privi.com/Downloads/Policies- PSCL/PSCL-Policv-on-Related-Partv-Transactions-V-1-1.pdf

All related party transactions entered during FY 2022-23 were on arm's length basis, in the ordinary course of business and were in compliance with the applicable provisions of the Act and the Listing Regulations. An omnibus approval is obtained for related party transactions which are of repetitive nature and entered in the ordinary course of business and on arm's length basis. A statement giving details of all related party transactions entered pursuant to omnibus approval so granted is placed before the Audit Committee on a quarterly basis for its review.

The Company has not entered any contracts or arrangements with related parties in terms of Section 188(1) of the Act and there were no material significant related party transactions entered into by the Company with Promoters, Directors, KMPs or other designated persons which may have a potential conflict with the interest of the Company at large. Accordingly, the disclosure of related party transactions as required under Section 134(3)(h) of the Act in Form No. AOC-2 is not applicable to the Company for FY 2022-23 and hence does not form part of this Report.

Pursuant to Regulation 23 of the Listing Regulations, the Company submits details of related party transactions on a consolidated basis to the stock exchanges as per the specified format on a half-yearly basis.

The details of Related Party Transactions are provided in the accompanying Financial Statements.

INTERNAL CONTROL AND ITS ADEQUACY:

Adequate internal control systems commensurate with the nature of the Company's business, size and complexity of its operations are in place and have been operating effectively. The Directors have laid down policies and procedures which are adopted by the company for ensuring the orderly and efficient conduct of its business, including adherence to Company 's policies, the safeguarding of its assets, the prevention and detection of frauds and errors, the accuracy and completeness of the accounting records, and the timely preparation of reliable financial information;

Apart from this your Company has also engaged a full- fledged professional Internal Audit firm to test and check the Internal Controls of all systems and suggest corrective and remedial measures.

The Audit Committee deliberated with the members of the Management, considered the systems as laid down and met the internal audit team and statutory auditors to ascertain their views on the internal financial control systems. The Audit Committee satisfied itself as to the adequacy and effectiveness of the internal financial control systems as laid down and kept the Board of Directors informed. However, the Company recognises that no matter how the internal control framework is, it has inherent limitations and accordingly, periodic audits and reviews ensure that such systems are updated on regular intervals. The Statutory Auditors have also issued a report on review of Internal Financial Controls (ICFR) and have expressed that the Internal Controls over Financial Reporting are adequate and operating effectively.

GOVERNANCE AND COMPLIANCE:

The Secretarial and Legal functions of the Company ensure maintenance of good governance at all levels. They assist the Company by being compliant in all areas including legislative expertise, corporate structuring, regulatory changes and governance. The Compliances across various locations are monitored through a Legal Risk Management System.

RISK MANAGEMENT POLICY:

The Company has put in place the Risk Management Plan as detailed in the Risk Management Policy which is approved by Board of Directors and adopted by the Company. The Risk Management Policy is uploaded on the Company's website at http://www.privi.com/Downloads/Policies-PSCL/PSCL-Risk- Mgmt-Policv.pdf.

The Policy provides a framework for identification, evaluation, management, continuous monitoring of risks and implementation of mitigation strategies. The risk management strategy is integrated with the overall business strategies of the organization and its mission statement to ensure that its risk management capabilities aid in establishing competitive advantage and allow management to develop reasonable assurance regarding the achievement of the Company's objectives.

The Risk Management Committee (RMC) oversees the risk management process in the Company. The RMC is chaired by an Independent Director and the Chairperson of Audit Committee is also a member of RMC.

A sub-committee consisting of the Head of the Department / Senior Leadership Team of the Company has been formed which meets monthly. A systematic review of risks identified is subject to a series of focused meetings of the empowered Sub-Committee. Each sub-committee member ensures the effectiveness of the risk monitoring process across his work area and the sub-committee makes assessment of long term, strategic, macro risks and implementation of mitigation strategies across business units.

REPORTING OF FRAUD:

During the year, the Statutory Auditors, Cost Auditors and Secretarial Auditors have not reported any instances of frauds committed in the Company by its officers and employees under Section 143(12) of the Act details of which needs to be mentioned in this Report.

CORPORATE SOCIAL RESPONSIBILITY:

The Corporate Social Responsibility Committee has formulated and recommended to the Board a Corporate Social Responsibility Policy which has been approved by the Board. The other details of the CSR activities as required under Section 135 of the Act are given in the CSR Report as Annexure to this Report.

VIGIL MECHANISM AND WHISTLEBLOWER POLICY:

As required under the Act and Listing Regulations, the Company has devised an effective Whistleblower mechanism enabling stakeholders, including individual employees and their representative bodies to communicate their concerns about illegal or unethical practices freely. The Company has adopted a Vigil Mechanism and Whistleblower Policy ('the Policy') for stakeholders to report concerns about any unethical behavior, actual or suspected fraud or violation of the Company's Code of Conduct. Protected disclosures can be made by a whistleblower through several channels. The Policy provides for adequate safeguards against victimization of employees. No personnel of the Company have been denied access to the Chairperson of the Audit Committee. The Policy also facilitates all employees of the Company to report any instance of leakage of unpublished price sensitive information.

Vigil Mechanism and Whistle Blower Policy is available on the Company's Website at https://www.privi.com/Downloads/Policies- PSCL/PSCL-Vigil-Mechanism-Policy-V-1-1.pdf

SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013:

The Company has adopted a policy on prevention, prohibition and redressal of sexual harassment at workplace in line with the provisions of the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 and the Rules made thereunder. The Company has also constituted Internal Complaints Committee (ICC) for its workplaces to address complaints pertaining to sexual harassment in accordance with the POSH Act.

No complaints were pending at the beginning of the financial year. No complaint was pending as at the end of the financial year.

To build awareness in this area, the Company has been conducting awareness sessions during induction of new employees and also periodically for permanent employees, third-party employees and contract workmen through online modules and webinars.

MEETINGS OF THE BOARD:

During the Financial Year 2022-23, 4 (Four) meetings of the Board of Directors took place. For further details, please refer to the Corporate Governance Report annexed hereto.

PARTICULARS OF LOANS GUARANTEES AND INVESTMENTS:

Particulars of loans, guarantees and investments made by the Company as required under Section 186 (4) of the Act are contained in Note No. 5, 13, 14 and 30 to the Standalone Financial Statements.

CORPORATE GOVERNANCE REPORT:

A Report on the Corporate Governance along with a certificate from a Practicing Company Secretary regarding the compliance of conditions of Corporate Governance as stipulated in Regulation 34 of Listing Regulations, 2015 as also the Management Discussion and Analysis Report are annexed to this Report.

AUDITORS

I. STATUTORY AUDITORS AND THEIR REPORT:

The auditors M/s. BSR & Co. LLP, Chartered Accountants were appointed as Statutory Auditors at the 35th Annual General Meeting (AGM) held on November 02, 2020, for a term of five years, from the conclusion of 35th AGM till the conclusion of 40th AGM to be held in the year 2024-25. They have furnished a declaration confirming their independence as well as their arm's length relationship with the Company and that they have not taken up any prohibited non-audit assignments for the Company. The Board has duly reviewed the Statutory Auditor's Report for the Financial Year ended on March 31, 2023, and the observations and comments, appearing in the report are self-explanatory and do not call for any further explanation / clarification by the Board in their Report as provided under Section 134 of the Act.

II. SECRETARIAL AUDITORS AND SECRETARIAL AUDIT REPORT:

As required by Section 204 of the Act, read with The Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, the Board has appointed M/s. Rathi & Associates, Company Secretaries, a firm of Company Secretaries in Practice to conduct Secretarial Audit for the Financial Year 2022-23. The Report of the Secretarial Audit for the financial year ended on March 31, 2023, is annexed to this Report.

The Board has reviewed the Secretarial Auditor's Report and is of the opinion that the observations and comments, appearing in the report are self-explanatory and do not call for any further explanation / clarification by the Board in its Report as provided under Section 134 of the Act.

III. COST AUDITORS:

As per the Companies (Cost Records and Audit) Rules, 2014 as amended by Companies (Cost Records and Audit) Amendment Rules, 2014, issued by the Central Government, the Company is required to get its cost records maintained by it for the products covered under Chapters 2902, 2903, 2905, 2906, 2907, 2909, 2912, 2914, 2915, 2918, 2926 and 2932 of Sr. No. 18 of table mentioned under Rule 3 (B) - Non-regulated Sectors audited by a Cost Auditor.

The Board of Directors has on the recommendation of the Audit Committee appointed M/s Kishore Bhatia & Associates, Cost Accountants as the Cost Auditors of the Company for the financial year 2023-24. Pursuant to the provisions of Section 148 of the Act read with The Companies (Audit and Auditors) Rules 2014, Members are requested to consider the ratification of the remuneration payable to M/s. Kishore Bhatia & Associates.

CONFIRMATION OF COMPLIANCE OF SECRETARIAL STANDARDS:

During the year under review, the Company has complied with the applicable Secretarial Standards i.e. SS-1 and SS-2, relating to "Meetings of the Board of Directors" and "General Meetings", respectively, issued by The Institute of Company Secretaries of India (ICSI).

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, AND FOREIGN EXCHANGE EARNINGS AND OUT GO:

A. CONSERVATION OF ENERGY

I. IMPACT ON ENERGY CONSERVATION IN 2022-23:

• Dry vacuum pumps (10 nos. of Ital vac make) installed to save Power consumption, Steam consumption and Effluent load reduction.

• Reduction in Boiler feed water consumption (Distilled Mineral Water) preheating, by utilising distillation columns top condensers heat and reduction of Cooling Tower Load.

• We generated 2815 MWH power from 500 KW steam Turbine in 2022-23.

• VFDs are provided on the vacuum Pumps, Cooling Tower Pumps, Fans and Reactor agitators for optimising the power consumption.

• Replaced the regular and CFL lighting with energy efficient LED lighting across all plants.

• By recycling Treated effluent water (ZLD ~ 450-500 KLD), specific consumption of water has been brought down significantly to almost NIL in some of the plants.

• Rainwater harvesting done and same is used for process applications and gardening.

• 925 KWH Captive power plant installed at Unit -4. The same shall start in May-2023.

• Solar Power (400 KWH) installed & working.

II. ENERGY CONSERVATION PLANNING FOR 2022-23/ CAPITAL INVESTMENT:

• Alpha-Pinene to Camphene yield improvement (0.7 to 0.8) at low temperature and with modified Catalyst.

• Batch Process to Continuous Reaction and distillation (Terpeniol to Terpeniol Epoxide distillation and Camphene distillation).

• Recycle of Sulfuric acid and Phosphoric acid to save/ minimize acid consumption in manufacturing process and reduction in material cost.

• Value added products derivation from the side stream of various production processes with purification.

• Green Technology development at pilot scale from intermediates of Products.

• ZLD plant to recycle treated effluent water and hence reduction in overall water consumption.

III. New Process Developments :

• Recycle of H3PO4 (AI/TT etc.) to minimize RM consumption.

• To introduce Amber extreme as a new product in Unit 2.

• To introduce two new products Cashmerone and Couvane at Unit 6.

• New technology for separation/dehydration (Pervaporation Process) to eliminate conventional distillation for solvent dehydration to save steam.

• Waste Heat recovery from Pyrolysers Flue gases and generate ~ 160 TR chilled water at temperature (+) 7?C.

• 925 KWH Captive power plant installed at Unit -4 to start in May-2023.

B. TECHNOLOGY ABSORPTION

The expenditure on Research and Development: Yes

(' In Lakhs)
Sr. Particulars No. Amount
a. Capital 91.88
b. Revenue 537.11
Total (a+b) 628.99
Total Research & Development Expenses as % of Turnover 0.40%

C. FOREIGN EXCHANGE EARNINGS AND OUTGO

(' In Lakhs)
Particulars Amount
Foreign Exchange Earnings 1,20,797.60
Foreign Exchange Outgo 87,386.38

Annual Return:

Pursuant to Section 92(3) of the Act read with Section 134(3)(a) of the Companies Act and the applicable Rules, the Annual Return in Form MGT-7 shall be available on Company's Website at https:// www.privi.com/investor-relations/reports/annual-return.

ACKNOWLEDGEMENTS:

Your Directors' value the consistent support and encouragement given by Customers, Suppliers, Bankers, Business Associates and Government Agencies to the Company. The Board of Directors also join us in applauding the employees at all levels for their dedication, hard work and support at all times.

For and on behalf of the Board of Directors
Mahesh P Babani
Place: Navi Mumbai Chairman & Managing Director
Date: May 29, 2023 DIN - 0051162

   

Privi Speciality Chemicals Ltd Company Background

Mahesh BabaniMahesh Babani
Incorporation Year1985
Registered OfficePlot No A-71 TTC,Thane-Belapur Road
Navi Mumbai,Maharashtra-400709
Telephone91-022-27783040/27783041,Managing Director
Fax91-022-27783049
Company SecretaryAshwini Saumil Shah
AuditorB S R & Co LLP
Face Value10
Market Lot1
ListingBSE,NSE,
RegistrarLink Intime India Pvt Ltd
C-101 247 Park,L B S Marg,Vikhroli West,Mumbai-400083

Privi Speciality Chemicals Ltd Company Management

Director NameDirector DesignationYear
Mahesh BabaniChairman & Managing Director2023
D B RaoExecutive Director2023
Rajesh BudhraniNon-Exec. & Independent Dir.2023
P R BarpandeNon-Exec. & Independent Dir.2023
Anurag SuranaNon-Exec. & Independent Dir.2023
D T KhilnaniNon-Exec. & Independent Dir.2023
ANURADHA EKNATH THAKURIndependent Director2023
Ashwini Saumil ShahCompany Sec. & Compli. Officer2023
Hemang Manhar GandhiAdditional Director2023

Privi Speciality Chemicals Ltd Listing Information

Listing Information
BSE_500
BSESMALLCA
BSEALLCAP
BSEMETERIA
SML250
MSL400

Privi Speciality Chemicals Ltd Finished Product

Product NameUnit Installed
Capacity
Production
Quantity
Sales
Quantity
Sales
Value
Sale of ProductsNA0001575.4182
Other Operating IncomeNA0002.425
Deodorizer DistillateMT0000
OthersNA0000
Fatty AcidsMT0000
Dimer Fatty AcidMT0000
Fatty Oil.NA0000

Contact us Contact us